Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis
Symptom C0009450|infection
Sentences 1297
PubMedID- 22421553 Background: unsafe injecting practices put injecting drug users (idus) at repeat exposure to infection with the hepatitis c virus (hcv).
PubMedID- 20823335 We employed this clustering feature to define knockdowns which harm viral infection efficiency of human hepatitis c virus.
PubMedID- 25807146 The seronegative participants had an average bmi of 23.9 and a median bmi of 23.8. the seropositive participants had an average bmi of 22.4 and a median bmi of 22.2. we also examined chronic co-infection with hepatitis b and c, two common viruses that are known to cause chronic infection.
PubMedID- 21746810 Unlike liver cirrhosis, which, in many developing countries frequently follows chronic infection with hepatitis b or c virus, pulmonary fibrosis, and particularly idiopathic pulmonary fibrosis (ipf)—the most frequent and devastating form of the disease—typically follows noninfectious (i.e., physicochemical) tissue injury (rogliani et al., 2008).
PubMedID- 25588648 infection with hepatitis type c virus (hcv) is an important epidemiologic problem and one of the most common causes of liver diseases worldwide.
PubMedID- 25652705 Both expert reports also commented, that the main risk factor for liver cancer is infection with hepatitis b or c, but that an association between alcohol and liver cancer has been shown both among people infected with hepatitis-virus as well as those not infected .
PubMedID- 23936443 Etiology studies indicate that infection with a hepatitis virus (hbv or hcv) and the dysregulation of genes involved in cell proliferation are major risk factors for hepatocarcinogenesis .
PubMedID- 24147097 Concurrent infection with hepatitis c virus (hcv) and hepatitis b virus (hbv) was not uncommon in china.
PubMedID- 23527168 Background: sub-saharan africa carries a high burden of co-infection with hiv-1 and hepatitis b virus (hbv).
PubMedID- 22894766 Chronic infection with hepatitis c virus (hcv) is the predominant aetiology for the development of hepatocellular carcinoma (hcc) worldwide .
PubMedID- 24376578 Previous epidemiological studies have identified that major risk factors for the development of hcc are chronic infection with hepatitis b virus (hbv) or hepatitis c virus (hcv), liver cirrhosis, habitual alcohol abuse, and exposure to aflatoxin b1 .
PubMedID- 23696852 Exclusion criteria were co-infection with hepatitis b or c, other acute or chronic ongoing infections, malignant disease, immunosuppressive treatment, and pregnancy.
PubMedID- 22007310 These patients may have a concurrent infection with hepatitis b or c virus which needs evaluation.
PubMedID- 20557368 Two week induction of interferon-beta followed by pegylated interferon alpha-2b and ribavirin for chronic infection with hepatitis c.
PubMedID- 20735940 §co-infection with hepatitis c virus and hepatitis b virus.
PubMedID- 23870415 infection with hepatitis b virus (hbv) may lead to acute or chronic hepatitis.
PubMedID- 24103591 According to wong et al., infection with hepatitis c virus is the leading cause in approximately 30% of liver transplantation, 40% of cases of decompensated cirrhosis and 60% of hepatocellular carcinoma 2.
PubMedID- 25685452 These classes have been linked to respective clinical manifestations and depend on the stage of evolution of the host’s immune response, extent of associated hepatic fibrosis and co-infection with salmonella or hepatitis c. secondary amyloidosis develops in 15% of such patients, representing a critical impairment of macrophage function.
PubMedID- 26213549 hepatitis associated with mycoplasma pneumoniae infection in korean children: a prospective study.
PubMedID- 24910705 Factors of renal disease history, first-degree relative infection with hepatitis b, blood transfusion, history of operation in hospital, circumcision, history of contact with a hepatitis b-infected patient, imprisonment history, iv drug abuse history, and smoking had a significant association with disease seroprevalence.
PubMedID- 22701774 It appears that the transmission of, and infection with, hepatitis b virus poses the greatest risk for both patients and the dental team, based on the incidence and risk of transmission.
PubMedID- 26214477 Reduced cortisol in the absence of bacterial infection in patients with hepatitis b virus cirrhosis.
PubMedID- 22546735 Occult infection with hepatitis c virus: friend or foe.
PubMedID- 21415943 The active continuous population movement through travel, tourism and migration from and to the south mediterranean countries contribute to the spread of infections due to hepatitis viruses across borders leading to outbreaks and emergence of new patterns of infection or introduction of uncommon genotypes in other countries, particularly in europe.
PubMedID- 23206959 Cirrhosis of different etiologies such as alcohol, primary biliary cirrhosis, or chronic infection with hepatitis b or c (hbv, hcv) are risk factors that predispose patients to hcc2.
PubMedID- 22195250 The infection source of acute hepatitis a was almost exclusively unknown origin in both groups (93.3% in the positive group vs 95.0% in the negative group).
PubMedID- 24373091 Hepatocellular carcinoma (hcc) is a frequent, long term complication of chronic infection with hepatitis b virus (hbv) with an annual incidence ranging from 2 to 5%, often independent from the histological stage of underlying liver disease and serological status.
PubMedID- 21994686 Hbv infection clearly contrasted with hepatitis c virus (hcv) infection in the same model; indeed, hcv infection is accompanied by a profound modification of cellular gene expression, in particular of isgs.
PubMedID- 20429960 Chronic infection with hepatitis b virus (hbv) occurs in approximately 6% of the world's population and carriers of the virus are at risk for hepatocellular carcinoma and cirrhosis.
PubMedID- 26334902 Approximately 75 to 80% of hcc patients are in the asia-pacific region,1 where hcc incidence is driven by the spread of chronic infection with hepatitis b and c virus (hbv/hcv), which leads to liver cirrhosis.
PubMedID- 20002561 infection with the hepatitis c virus commonly occurs in patient groups who have difficulty accessing conventional medical care, reducing their chance of successful antiviral therapy.
PubMedID- 21914084 Chronic infection with hepatitis c virus (hcv) can induce insulin resistance (ir) in a genotype-dependent manner and contributes to steatosis, progression of fibrosis and resistance to interferon plus ribavirin therapy.
PubMedID- 25374720 Pleuro-pulmonary nocardiosis as opportunistic infection in a patient with chronic hepatitis c under combination treatment with pegylated interferon, ribavirin, and boceprevir.
PubMedID- 22537438 Recently developed drugs and innovative strategies for the treatment of chronic infection with genotype 1 hepatitis c virus (hcv) have become the standard of care.
PubMedID- 25170193 Chronic infection with hepatitis c virus (hcv) is a leading cause of liver-related morbidity and mortality worldwide and predisposes to liver fibrosis and end-stage liver complications.
PubMedID- 22276183 Chronic infection with hepatitis b virus (hbv) is a major worldwide issue in public health and is one of the best known high-risk factors for cirrhosis and hepatocellular carcinoma (hcc) .
PubMedID- 20375957 Conclusion: infection with hsv-2 and hepatitis c virus (hcv) was inversely associated with fars, independent of multiple confounders.
PubMedID- 23776577 The following exclusion criteria were used: (1) non-adult study population, liver transplantation recipients or pregnancy; (2) ae occurring in patients receiving chemotherapy, immunosuppressive therapy or anti-hbv therapy; (3) interferon, traditional chinese medicine, stem cells or corticoids treatments; (4) co-infection with hepatitis a, c, d, e virus, epstein-barr virus, cytomegalovirus or human immunodeficiency virus (hiv); (5) other concomitant liver diseases such as autoimmune hepatitis, alcoholic liver disease, drug-induced liver injury or wilson’s disease.
PubMedID- 22359980 The only reliable way of prevention of this infection is immunisation with hepatitis b vaccine.
PubMedID- 22550527 Various factors have been proposed as predictors of svr, including hcv genotype, hcv rna levels, the dose and duration of therapy, body mass index, age, insulin resistance, gender, stage of fibrosis, and co-infection with other hepatitis viruses or hiv 6.
PubMedID- 22807544 Abnormal levels of liver enzymes are common in hiv-infected patients and may be caused by multiple factors, including co-infection with hepatitis c virus (hcv) or hepatitis b virus (hbv) infection and in the majority of cases by antiretroviral drug-related liver injury.
PubMedID- 21449783 Background: peginterferon-ribavirin therapy is the current standard of care for chronic infection with hepatitis c virus (hcv).
PubMedID- 23358556 infection with hepatitis c virus (hcv) is a worldwide health problem, with more than 170 million individuals infected.
PubMedID- 21044142 Persistent infection with hepatitis c virus causes serious liver diseases, such as chronic hepatitis, hepatic cirrhosis and hepatocellular carcinoma.
PubMedID- 23449352 The major risk factors are infection with hepatitis b and c virus, which increase the risk of liver cancer 20-fold.
PubMedID- 24212770 The primary risk factors for hcc include infection with hepatitis b and hepatitis c viruses, and long-term exposure to aflatoxin 3.
PubMedID- 21573126 While several causal agents for hcc have been identified, including infection with hepatitis b and c viruses (hbv and hcv), there is no effective treatment for this cancer type, in part because the molecular and cellular mechanisms of hcc development are still poorly understood , , .
PubMedID- 24691105 This condition is the end result of long-term (chronic) liver damage caused by, for example, alcohol abuse or infection with hepatitis b virus (hbv).
PubMedID- 22229496 Objective: infection with hepatitis b virus (hbv) is endemic among arctic populations where it may have a benign course.
PubMedID- 22577025 A combination of protein c and retinol-binding protein 4 in serum gave promising preliminary results as candidate biomarkers to distinguish patients at different stages of hepatic fibrosis due to chronic infection with hepatitis c virus (hcv).

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26